DrugDashboards

Triple Antibiotic Plus

Polymyxin B Sulfate, Bacitracin Zinc, Neomycin Sulfate, Pramoxine HCl · POLYMYXIN B SULFATE 10000 [USP'U]/g; BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN 3.5 mg/g; PRAMOXINE HYDROCHLORIDE 10 mg/g · Ointment · Topical · Cosette Pharmaceuticals, Inc.

NDC 00713-0622-31 · 28.4 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.1272 per gram over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Nov 2013Sep 2026$0.1272
155 price points · per GMSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$3.59
Reported to Texas DSHS · 2026 annual filing · Cosette Pharmaceuticals, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$4,104
494 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for bacitracin zinc, neomycin sulfate, polymyxin b, pramoxine hcl (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
M004
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Polymyxin B Sulfate, Bacitracin Zinc, Neomycin Sulfate, Pramoxine HCl (Ointment)

LabelerStrengthFirst seenLast seen
Cosette Pharmaceuticals, Inc.POLYMYXIN B SULFATE 10000 [USP'U]/g; BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN 3.5 mg/g; PRAMOXINE HYDROCHLORIDE 10 mg/gAug 26, 2026Sep 2, 2026
Cosette Pharmaceuticals, Inc.POLYMYXIN B SULFATE 500 [USP'U]/g; BACITRACIN ZINC 3.5 mg/g; NEOMYCIN 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/gJul 22, 2026Aug 19, 2026
Cosette Pharmaceuticals, Inc.BACITRACIN ZINC 500 [USP'U]/g; NEOMYCIN 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Triple Antibiotic Plus — NDC 00713-0622-31," retrieved September 3, 2026, https://drugdashboards.com/drug/00713062231.

Free to cite with attribution — see how the data is put together.